Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-1093a in healthy male subjects
NCT02142400Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in anemia comparing DS-1093 with Placebo (2 arms). Primary endpoints: Blood concentration of DS-1093 at Day 15 and Number of adverse events including type and severity at Day 98. Started May 2014; status: completed.
02
Drugs
DS-1093a
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02142400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02142400.